Please login to the form below

Not currently logged in
Email:
Password:

eczema

This page shows the latest eczema news and features for those working in and with pharma, biotech and healthcare.

Sanofi raises profit forecast following positive Q2 results

Sanofi raises profit forecast following positive Q2 results

Sales for Q2 were driven by the company’s eczema drug and its vaccines portfolio. ... Sales for the quarter to June 2021 “grew by double digits” to 8.7bn (up by 12.4% at CER), driven by the company’s eczema drug Dupixent (dupilumab) and its

Latest news

More from news
Approximately 8 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    Dupixent for eczema and asthma – in order to ramp up internal generation of new drug candidates.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Meanwhile, phase 2b results for upadacitinib showed that the drug was able to improve skin lesions and itching in patients with moderate-to- severe atopic dermatitis (eczema) across all doses tested,

  • Case Study: Skin-telligence Case Study: Skin-telligence

    One in two eczema sufferers aren’t happy with their treatment regime and actively switch products, trying different treatments to find the right one. ... Eczema has a psychological impact. Half of respondents said their skin affects their confidence.

  • Embracing digital disruption in pharma Embracing digital disruption in pharma

    HelloSkin is the number one online store for emollients, nutrition supplements, accessories and selected over-the-counter products for people living with psoriasis, eczema, acne and dry skin.

  • Deal Watch May 2016 Deal Watch May 2016

    Paying a 55% premium at $99.25 per share, the acquisition brings crisaborole, a topical PDE4 inhibitor for mild to moderate atopic dermatitis (eczema) with estimated peak sales of $2bn. ... Corporate acquisition. Acquisition for $99.25 per share [55%

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Guide
How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...